Innovator company

On the supply side, patents allow the innovating company considerable discretion in pricing their new products. However, new products may be complements or substitutes of those of rival companies. In reality, pharmaceutical firms operate in oligopolistic markets characterized by a limited number of competitors (especially in submarkets such as that of cardiovascular products, for example), differentiated products and competitive innovation strategies. 

Subsequent rocketing oil and natural gas prices along with the concomitant action of venture capitalists changed all that. The price of energy and of traditional raw materials suddenly multiplied by a factor three or more. The route to innovative companies in the chemical industry is now open again. 

Innovation process Small innovative companies started in the seventies to develop alternative stripping agents. However, up to now these products represent only a niche market. Even though the DCM market declined between 1986 and 2000 in Germany (about 80 %), substitution of DCM was limited to aerosols and adhesives. Also improved emission reduction in industrial plants lowered the consumption of DCM. 

Understandably, the impurity profiles of the same drug substance produced by different S3mthetic routes will differ qualitatively and quantitatively. This is commonly observed when a drug substance is provided by different suppliers. For example, the HPLC chromatograms from samples of fluoxetine hydrochloride obtained from four different suppliers show the differences in the impurities produced by the presumably different synthetic routes (Figure 1.1) [7]. Supplier A is the innovator company. Supplier B is in Italy, and Suppliers C and D are in India. 

Documentation of innovation depression in pesticides, another area that requires pre-market registration is equally as dramatic. William Tucker, in his very recent Of Mites and Men, (23) discusses the frustration of several innovative companies trying to develop biological controls instead of target-specific toxic insecticides. Like Grabowski and drugs, Dr. Wendell Mullison reported in 1975 that since the enactment of FEPCA, the pesticide Act of 1971, the number of major pesticides introduced has fallen from two per year in the 1960 to 1970 decade to less than one per year for the period 1971 to 1975 (24). 

Naturally, to turn innovation into business success a company has to understand its craft very thoroughly. Liquid crystal production can require very complicated, multi-level syntheses, and mixture development is far from a trivial process. But any innovative company - no matter how skilled - will struggle to create value from its innovations if it does not listen to and work with its customers. 

For Innovator Companies The act encouraged continued innovation, research, and development activities by providing manufacturers with meaningful incentives in the form of patent protection/restoration and marketing exclusivity, thus allowing them to recoup some of their investments. 

Successful commercialization of innovations. Good indicators here are the number and sales of innovations achieved over the last few years and their share of total sales. Innovative companies find that recently launched products generate major revenues compared with the rest of their portfolios. 

A challenging job in an international and innovative company that is leading in its field You will get the opportunity to work with the most advanced technology together with highly skilled colleagues. 

Patent lawsuits based on the Act are rare because generally challenges to patents on prescription medicines are rare. FDA reports that of 8,259 generic applications filed between 1984 and 2001, only 6% raised a patent issue, the necessary condition for patent litigation. According to the Federal Trade Commission, more than one-quarter of patent challenges studied did not result in a lawsuit by the innovator company. Since enactment of the law, generic company share of prescription medicine use has increased from 19% of prescription units in 1984 to 50% today. 

---